{
  "first_published_at": "2007-08-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON079097", 
  "title": "α-1 adrenoreceptor antagonists: intraoperative floppy iris syndrome", 
  "tags": "{\"parsed_therapeutic\": [\"urology-nephrology\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Urology and nephrology\"]}", 
  "_document_number": 333, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "urology-nephrology"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>&#945;-1 adrenoreceptor antagonists: intraoperative floppy iris syndrome</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: August 2007</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!---->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div id=\"dsuSynopsis\" class=\"yellow\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"dsuArticlePadding\">\r\n\t\t\t\t\t\t\t\t\t<span id=\"dsuSynopsisTitle\"><b>Summary</b></span>\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<br>Cataract surgeons should inquire about past or current use of &#945;-1 adrenoreceptor antagonists for prostatic hypertrophy<br>\t\r\n\t\t\t\t\t\t\t\t\t</div>         \t\t\r\n\t\t\t\t\t\t\t\t\t<div id=\"dsuSynopsisCut\">\r\n\t\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Data have accumulated to suggest that intraoperative floppy iris syndrome (IFIS) is a possible class effect of &#945;-1 adrenoreceptor antagonists, which are used to treat benign prostatic hyperplasia. IFIS is a newly identified syndrome that can lead to surgical complications during cataract surgery.</p><p>An association between IFIS and the &#945;-1 adrenoreceptor antagonist tamsulosin has previously been identified and advice communicated to healthcare professionals.<cite><a href=\"ssLINK/CON2023860\" target=\"_blank\">Current Problems in Pharmacovigilance 2006; 31: 6</a>.</cite><cite><a href=\"http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/Monthlylistsofinformationforhealthcareprofessionalsonthesafetyofmedicines/CON2024695\" target=\"_blank\">Letter to healthcare professionals, sent July, 2006</a>.</cite> A warning is now being added to the product information for all &#945;-1 adrenoreceptor antagonists, advising patients to inform their cataract surgeon about past or current use of these medicines before surgery to ensure that appropriate measures are in place should IFIS occur.</p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update August 2007; Vol 1, Issue 1: 4-5.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Data have accumulated to suggest that intraoperative floppy iris syndrome (IFIS) is a possible class effect of &#945;-1 adrenoreceptor antagonists, which are used to treat benign prostatic hyperplasia. IFIS is a newly identified syndrome that can lead to surgical complications during cataract surgery.</p><p>An association between IFIS and the &#945;-1 adrenoreceptor antagonist tamsulosin has previously been identified and advice communicated to healthcare professionals.<cite><a href=\"http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON2023860\" target=\"_blank\">Current Problems in Pharmacovigilance 2006; 31: 6</a>.</cite><cite><a href=\"http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/Monthlylistsofinformationforhealthcareprofessionalsonthesafetyofmedicines/CON2024695\" target=\"_blank\">Letter to healthcare professionals, sent July, 2006</a>.</cite> A warning is now being added to the product information for all &#945;-1 adrenoreceptor antagonists, advising patients to inform their cataract surgeon about past or current use of these medicines before surgery to ensure that appropriate measures are in place should IFIS occur.</p><p>&#160;</p><p><em>Article citation: Drug Safety Update August 2007; Vol 1, Issue 1: 4-5.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2007-08-01", 
  "date_last_modified": "2010-08-24", 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": "Current Problems in Pharmacovigilance 2006; 31: 6", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ssLINK/CON2023860", 
      "filename": "downloads/bd5c902e870caed1ff4fab1c48a5846d04151cad/con2023860.pdf", 
      "original_filename": "con2023860.pdf"
    }
  ], 
  "_item_id": 333, 
  "summary": "Cataract surgeons should inquire about past or current use of α-1 adrenoreceptor antagonists for prostatic hypertrophy", 
  "body": "Article date: August 2007\n\nData have accumulated to suggest that intraoperative floppy iris syndrome (IFIS) is a possible class effect of α-1 adrenoreceptor antagonists, which are used to treat benign prostatic hyperplasia. IFIS is a newly identified syndrome that can lead to surgical complications during cataract surgery.\n\nAn association between IFIS and the α-1 adrenoreceptor antagonist tamsulosin has previously been identified and advice communicated to healthcare professionals.[^1] [^2] A warning is now being added to the product information for all α-1 adrenoreceptor antagonists, advising patients to inform their cataract surgeon about past or current use of these medicines before surgery to ensure that appropriate measures are in place should IFIS occur. \n\n \n\nArticle citation: Drug Safety Update August 2007; Vol 1, Issue 1: 4-5.\n\n[^1]: [ASSET_TAG](#ASSET0).\n\n[^2]: [Letter to healthcare professionals, sent July, 2006](http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/Monthlylistsofinformationforhealthcareprofessionalsonthesafetyofmedicines/CON2024695).\n"
}